This is a new working class of Medicine, the doors now will swing wide open now. Prior to this set of trials,failure..Ask your self,why isn't this one of the best buyout candidates of recent years?I don't think the immenseness of what happened today has sunk in yet..They call it a buying opportunity!!
I try to be a realist..And thought long and hard before I posted,I'm with you on this..
Please keep this in mind..This is a new working class of Medicine, the doors now will swing wide open now. Prior to this set of trials,failure..Ask your self,why isn't this one of the best buyout candidates of recent years?I don't think the immenseness of what happened today has sunk in yet..
KETCHING tomorrow..No one wants to get left behind..
You had better be in it if that's so. With these results this could head in so many directions...but they will ALL be up!
declared successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated with human papillomavirus (HPV) types 16 or 18. Treatment with VGX-3100, Inovio’s HPV16/18-specific immunotherapy, resulted in histopathological regression of CIN2/3 to CIN1 or no disease, meeting the study’s primary endpoint. In addition, the trial demonstrated clearance of HPV in conjunction with regression of cervical lesions. Robust T-cell activity was detected in subjects who received VGX-3100 compared to those who received placebo.
Sentiment: Strong Buy
Is more than in the cards....The first of the low hanging fruit!!
(Reuters) - Inovio Pharmaceuticals Inc said its drug to treat abnormal growth of pre-cancerous cells on the surface of the cervix met its main goal in a mid-stage trial.
Inovio shares jumped 27 percent to a three-month high of $14.14 on the American Stock Exchange. They were up 23.5 percent at $13.78 in morning trade.
The pre-cancerous cells, commonly know as cervical dysplasia, are caused by the human papillomavirus (HPV), a sexually transmitted disease. Left untreated, the condition can sometimes worsen to an early form of cancer.
The drug, code named VGX-3100, was effective in treating pre-cancerous cervical disease and cleared HPV infection, the company said.
You have no idea where this is going...its a moon shot..I shouldn't even tell you guys after the way you all treated me.You don't know the read thing when you see it do your dd...and get back to me..